Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

MercadoLibre

Realty Income Corp

When it comes to building a portfolio with resilience and growth potential, the mantra to buy long-term stocks continues to resonate with seasoned investors. The art of looking beyond short-term turbulence requires identifying stocks for long-term wealth, which may feel akin to navigating a labyrinth.

Buy Alert: 3 Long-Term Stocks Nearing Super Attractive Entry Points

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced 81 winners of college scholarships awarded through the Humana Foundation Scholarship Program. Scholarships provide up to $3,000 for postsecondary education for children of Humana employees. Annual awards are renewable for up to three years or until completion of a degree or program with a total possible award of $12,000. This year's scholarship recipie.

Humana Foundation Announces 2023 Scholarship Awards

Humana said it paid out fewer-than-expected claims for non-urgent surgery, and that helped the health insurer record better-than-expected second quarter profit.

Humana Profit Beats Forecasts as its Medical Costs Were Less Than Expected

Humana's (HUM) Q2 results gain from strong pharmacy revenues and revenue growth within the Insurance segment, partly offset by higher benefits expenses.

Humana (HUM) Q2 Earnings Beat on Strong Individual MA Unit

Humana Inc. (NYSE:HUM ) Q2 2023 Earnings Conference Call August 2, 2023 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - President and CEO Susan Diamond - CFO Conference Call Participants Stephen Baxter - Wells Fargo A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Nathan Rich - Goldman Sachs Scott Fidel - Stephens Steve Valiquette - Barclays Michael Ha - Morgan Stanley Gary Taylor - Cowen Joshua Raskin - Nephron Research David Windley - Jefferies Kevin Fischbeck - Bank of America Operator Good morning and thank you for standing by.

Humana Inc. (HUM) Q2 2023 Earnings Call Transcript

Humana Inc. ( HUM , Financial) is a leading healthcare company that operates in the Healthcare Plans industry. As of August 2, 2023, the company's stock price stands at $482.89, with a market capitalization of $60.51 billion.

Humana Inc. (HUM): A Healthcare Giant with Good Outperformance Potential

Automatic Data Processing

CVS Health

Kraft Heinz

Private-sector payrolls for July, as reported by Automatic Data Processing ADP this morning, showed another surprise headline to the upside: +324K new private-sector jobs were filled last month, well ahead of the +175K expected. The previous month's jaw-dropping +497K (more than double expectations) has now been reduced to a still-very-robust +455K.

ADP Jobs +324K Still Higher than Expected; CVS, KHC, HUM Report

Private Sector Jobs Come in Higher Than Expected.

Private Sector Jobs Come in Higher Than Expected

While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Humana (HUM) Reports Q2 Earnings: What Key Metrics Have to Say

The results ease investor concerns after Humana and rival UnitedHealth Group warned of a surge in demand for non-urgent surgeries and outpatient services.

Humana shares rise after insurer says medical costs came in lower than expected

Medicare Advantage insurer Humana beat second-quarter earnings estimates, and lifted expectations for Medicare Advantage membership growth.

Humana Stock Is Rising. Earnings Beat Expectations.

Humana (HUM) came out with quarterly earnings of $8.94 per share, beating the Zacks Consensus Estimate of $8.88 per share. This compares to earnings of $8.67 per share a year ago.

Humana (HUM) Surpasses Q2 Earnings Estimates

Humana, which made big investments in its Medicare business, now says its individual enrollment in the popular Advantage plans would “grow by approximately 825,000 members in 2023.”

Humana Forecasts Bigger Medicare Advantage Growth Of 825,000 Members

Humana Inc.'s stock HUM, +0.28% rose 2.6% in premarket trade Wednesday, after the health insurance company topped earnings estimates for the second quarter and said the Medicare Advantage utilization environment was improving based on recent claims activity. Louisville, Ky.

Humana's stock up 1.6% premarket after health insurer says claims activity is stabilizing after June spike

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2023 (2Q23) versus the quarter ended June 30, 2022 (2Q22) and for the six months ended June 30, 2023 (YTD 2023) versus the six months ended June 30, 2022 (YTD 2022) as noted in the tables below. Consolidated income before income taxes and equity in net earnings (pretax results) In millions 2Q23 (a) 2Q22 (b) YTD 2023 (c) YTD 2022.

Humana Reports Second Quarter 2023 Financial Results; Affirms Full Year 2023 Adjusted EPS Guidance

Johnson & Johnson

Moderna

Healthcare has been a laggard this year. A slowpoke, a dawdler, an idler.

3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now

Humana's (HUM) second-quarter results are likely to reflect rising premiums and investment income.

Will Humana (HUM) Q2 Earnings Beat on Strong Pharmacy Business?

Apollo Commercial Real Estate Finance

Atmos Energy

Terex

Teekay Tankers

The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy HUM, TEX, ARI, ATO and TNK.

5 Low-Leverage Stocks to Buy Following the Fed Rate Hike

Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana (HUM) Earnings Expected to Grow: Should You Buy?

Deere & Company

T-Mobile US

Duke Energy

Cloudflare

Pinterest

Workday

Evercore analysts came up with stocks that the everyday investor can still afford to buy and can expect to make money off of.

T-Mobile, Deere, and 5 More Stocks That Should Gain After Earnings

The consensus price target hints at a 29% upside potential for Humana (HUM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Does Humana (HUM) Have the Potential to Rally 28.97% as Wall Street Analysts Expect?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Humana (HUM) Right Now?

Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Humana (HUM) Beat Estimates Again in Its Next Earnings Report?

MINISO Group Holding

Sunstone Hotel Investors

The equity market can be volatile at times and as an investor, if you want to play safe, buy stocks like HUM, TJX, SHO, ATO and MNSO.

5 Low-Leverage Stocks to Buy as Inflation Cools Down Slightly

Humana is close to a pure play on U.S. health insurance, especially Medicare. Comments from UNH's CEO in the middle of June regarding short-term challenges started an unjustified sell-off. Humana benefits from the growth in the elderly (65+) U.S. population and has high pricing power due to health insurance being a non-discretionary expense.

News for Humana Stock (HUM)